FDA

EOF: Food supplements banned

The ban on the marketing and sale of dietary supplements has been decided by the National Organisation for Medicines (EOF).

The preparations are branded SWANSON Czarny Bez Agaricus Echinacea, Immune Essentials and Reishi Mushroom by Pro Sport s.c. Mikolaj Filarski, Malgorzata Majdaniec, Poland (supplier).
.

The Raiting of US President Joe Biden continues to Fall

US President Joe Biden's public approval rating has fallen to 39% this month, approaching its lowest level since he took office, Reuters reported.

The results of the April 14-16 Reuters/Ipsos poll showed a modest drop from last month, when 42 percent of respondents said they approved of Biden's performance as president.

Μεσογειακή αναιμία: Εγκρίθηκε στις ΗΠΑ η πρώτη γονιδιακή θεραπεία για ασθενείς

Απόφαση-σταθμός στη «μάχη» για την οριστική αντιμετώπιση της θαλασσαιμίας από τον FDA

Prof. Mosialos – What applies to the vaccination of children 5 to 11 years old

Professor of Health Policy at LSE Elias Mosialos wrote on the approval of the coronavirus vaccine for children and specifically for the ages of 5 to 11 years, the , by posting an extended message on his personal Facebook account.

Prof. Mosialos refers to the clinical trials that were carried out until the licensing of vaccines for children aged 5 to 11 years.

Pfizer has Announced a Promising Treatment with Pills against COVID-19

Tests of experimental antiviral treatment against COVID-19 by the American company "Pfizer" (Pfizer) in the form of a pill have proved so promising that they have been shortened. The reason is that it reduced by 89% the risk of hospitalization or death in adults at risk of developing a severe form of the disease.

Κορωνοϊός - EMA: Ξεκινά την αξιολόγηση σε πραγματικό χρόνο του κοκτέιλ αντισωμάτων της AstraZeneca

Η AstraZeneca έχει ήδη καταθέσει αίτημα για επείγουσα χρήση του φαρμάκου στον αμερικανικό FDA

US authorizes Pfizer COVID booster for the elderly and high-risk

The United States has authorized the use of boosters of Pfizer's COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the population, amounting to tens of millions of Americans, are now eligible for a third shot six months after their second.

Pages